Evicenter
P&T meetings

Lonvoguran ziclumeran (lonvo-z)

Hereditary angioedema

Also known as NTLA-2002
Last updated
82 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Antifibrinolytics

2 evidence topics · 1 source

Tranexamic acid: reported prophylactic responses in HAE-FXII, HAE-PLG, and HAE with normal C1 inhibitor of unknown cause

“have shown favourable responses to LTP, particularly with tranexamic acid.” (opens the source at this quote in a new tab)

Androgens and antifibrinolytics: restriction on first-line use

“no longer recommended as first-line options” (opens the source at this quote in a new tab)